Silence Therapeutics
Generated by Meeveem AI
"Pioneering siRNA medicines to silence diseases and transform patient lives globally"
London
•51 - 250 Employees
•Biotechnology
About Silence Therapeutics
Silence Therapeutics pioneers precision engineered siRNA medicines that harness the body's natural RNA interference mechanism to silence disease-associated genes. With over 20 years of expertise, the company advances therapies for patients with limited treatment options, focusing on hematology, cardiovascular and rare diseases. Their proprietary mRNAi GOLD platform creates short interfering RNAs that precisely target disease-related messenger RNA. The company operates globally with locations in London, Hoboken and Berlin. As a Great Place to Work certified organisation in the UK, US and Germany, Silence combines a vibrant start-up mindset with the scientific rigour needed to deliver life-changing therapies for patients who are waiting.
88
Team Members
1994
Founded
Biotechnology
Sector
On-Site
Work Environment
Our Vision
A world where complex diseases are silenced through precision medicine, transforming lives globally and driving positive change for communities through innovative RNA-based therapies that address unmet patient needs.
Our Mission
At Silence, our mission is to use our technology to create a new generation of therapeutics which can improve outcomes for patients and, in the process, build shareholder value.